Paper36959214
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma.
Zhang P and 18 others. Nat Commun, 2023. Cited by 197 papers, by iCite.
Cite this record
ConductScience Library. STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. Papers, record 36959214. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36959214
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Glioblastoma | Major topic |
| Nanoparticles | Major topic |
| Animals | |
| Humans | |
| Mice | |
| B7-H1 Antigen | |
| CD47 Antigen | |
| Interferons | |
| STING Protein |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R37 CA266487 | NCI NIH HHS | United States | R37CA266487 | PubMed and NIH | NIH RePORTER |
| R01 NS110703 | NINDS NIH HHS | United States | R01NS110703 | PubMed | NIH RePORTER |
| R01 NS115955 | NINDS NIH HHS | United States | R01NS115955 | PubMed | NIH RePORTER |
| R01 NS106379 | NINDS NIH HHS | United States | R01NS106379 | PubMed | NIH RePORTER |
| R35 CA197725 | NCI NIH HHS | United States | R35CA197725 | PubMed | NIH RePORTER |
| P50 CA221747 | NCI NIH HHS | United States | P50CA221747 | PubMed and NIH | NIH RePORTER |
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27339708 | The role of myeloid cells in cancer therapies. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27339708 | PubMed |
| 2 | 12566411 | Dynamic changes during the immune response in T cell-antigen-presenting cell clusters isolated from lymph nodes. | J Exp Med | 2003 | https://conductscience.org/library/papers/12566411 | PubMed |
| 3 | 11927654 | IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. | J Leukoc Biol | 2002 | https://conductscience.org/library/papers/11927654 | PubMed |
| 4 | 27774519 | Radiotherapy: Changing the Game in Immunotherapy. | Trends Cancer | 2016 | https://conductscience.org/library/papers/27774519 | PubMed |
| 5 | 26419354 | Expanding global access to radiotherapy. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/26419354 | PubMed |
| 6 | 30689700 | The Macrophage 'Do not eat me' signal, CD47, is a clinically validated cancer immunotherapy target. | Ann Oncol | 2019 | https://conductscience.org/library/papers/30689700 | PubMed |
| 7 | 25622193 | Innate immune recognition of cancer. | Annu Rev Immunol | 2015 | https://conductscience.org/library/papers/25622193 | PubMed |
| 8 | 23504257 | Murine cell line model of proneural glioma for evaluation of anti-tumor therapies. | J Neurooncol | 2013 | https://conductscience.org/library/papers/23504257 | PubMed |
| 9 | 30385717 | Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. | JCI Insight | 2018 | https://conductscience.org/library/papers/30385717 | PubMed |
| 10 | 26210177 | Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy. | Biomaterials | 2015 | https://conductscience.org/library/papers/26210177 | PubMed |
| 11 | 32470397 | Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes. | Cell | 2020 | https://conductscience.org/library/papers/32470397 | PubMed |
| 12 | 34363319 | Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma. | CNS Neurosci Ther | 2021 | https://conductscience.org/library/papers/34363319 | PubMed |
| 13 | 27734112 | Anti-GITR therapy promotes immunity against malignant glioma in a murine model. | Cancer Immunol Immunother | 2016 | https://conductscience.org/library/papers/27734112 | PubMed |
| 14 | 25959818 | Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. | Cell Rep | 2015 | https://conductscience.org/library/papers/25959818 | PubMed |
| 15 | 30643263 | Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. | Nat Immunol | 2019 | https://conductscience.org/library/papers/30643263 | PubMed |
| 16 | 23475183 | Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells. | Nat Immunol | 2013 | https://conductscience.org/library/papers/23475183 | PubMed |
| 17 | 10856220 | Role of CD47 as a marker of self on red blood cells. | Science | 2000 | https://conductscience.org/library/papers/10856220 | PubMed |
| 18 | 32198351 | Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. | Nat Commun | 2020 | https://conductscience.org/library/papers/32198351 | PubMed |
| 19 | 24390738 | The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progression. | Cancer Res | 2014 | https://conductscience.org/library/papers/24390738 | PubMed |
| 20 | 19293190 | Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. | Cancer Res | 2009 | https://conductscience.org/library/papers/19293190 | PubMed |
Cited by118
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 197 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978966 | Intranasal nano-immunotherapy for glioma: bypassing the blood-brain barrier, reprogramming the immune microenvironment, and bridging preclinical validation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42978966 | PubMed |
| 42902412 | Nanoengineered STING agonists for cancer therapy: toward immunodynamic control. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42902412 | PubMed |
| 42892943 | EGFR-antibody-decorated cancer-cell-membrane-coated MOF nanoplatform enables targeted delivery of the STING agonist diABZI for pancreatic cancer immunotherapy. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42892943 | PubMed |
| 42881240 | Preclinical efficacy of a systemically-administered, second-generation STING agonist that promotes anti-tumour immunity in combination with radiotherapy. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42881240 | PubMed |
| 42835334 | STING-mediated tumor microenvironment remodeling: turning adaptive resistance into therapeutic vulnerability. | Front Immunol | 2026 | https://conductscience.org/library/papers/42835334 | PubMed |
| 42743926 | Gliomas phenocopy an inborn error of metabolism to drive neuronal activity and tumor growth. | Cell | 2026 | https://conductscience.org/library/papers/42743926 | PubMed |
| 42740837 | Research Progress of Multicomponent Co-Loaded Nanomedicine Delivery Systems for Tumor Immunotherapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42740837 | PubMed |
| 42705236 | Dendritic cell centric nanoengineering couples antigen acquisition and STING activation for cancer immunotherapy. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42705236 | PubMed |
| 42662312 | Fast-Food Component-Induced Epigenetic Modifications Modulate Immunotherapy in Metastatic Breast Cancer. | ACS Omega | 2026 | https://conductscience.org/library/papers/42662312 | PubMed |
| 42639384 | Reprogramming the immunosuppressive microenvironment in glioblastoma: the microglia-MDSC-Treg axis and translational therapeutic strategies. | Front Oncol | 2026 | https://conductscience.org/library/papers/42639384 | PubMed |
| 42557374 | The kinase CK1α coordinates the initiation and termination of the cGAS-STING pathway. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/42557374 | PubMed |
| 42549406 | Targeting replication stress in glioblastoma: From genotoxic treatment and inhibitors of the DNA damage response to immunotherapy. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42549406 | PubMed |
| 42503996 | Current Perspectives on STING Agonists for Anticancer Drug Development. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42503996 | PubMed |
| 42482991 | Targeting innate immunity to overcome immune evasion in HPV-associated cancers. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42482991 | PubMed |
| 42481451 | Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42481451 | PubMed |
| 42477364 | Protein corona guided albumin-binding paclitaxel nanoparticles for treatment of intracranial tumors. | Sci Rep | 2026 | https://conductscience.org/library/papers/42477364 | PubMed |
| 42464666 | Leveraging Mitochondria-Endoplasmic Reticulum Functional Interplay With an On-Demand Nanoparticle to Boost mtDNA-Based STING Immunotherapy. | Adv Mater | 2026 | https://conductscience.org/library/papers/42464666 | PubMed |
| 42375809 | Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances. | Mil Med Res | 2026 | https://conductscience.org/library/papers/42375809 | PubMed |
| 42322055 | A Self-Immunoregulatory Nanosensitizer for Sonodynamic Cancer Therapy. | Adv Mater | 2026 | https://conductscience.org/library/papers/42322055 | PubMed |
| 42281979 | DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types. | Res Sq | 2026 | https://conductscience.org/library/papers/42281979 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36959214
GET https://conductscience.org/api/papers/v1/36959214/references?page=2